{"transactions":[{"id":4636972,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Stock Option (right to buy)","published_at":"2026-10-07T20:07:54.000Z","date":"2026-10-05","kind":"exercise","planned":true,"acquired":false,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock Option is fully vested and exercisable."}],"balance_after":74068,"derivative":{"exercise_price":25.92,"expiration_date":"2032-08-08","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001960048-26-000013","document":"wk-form4_1791403671.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1960048/000196004826000013/wk-form4_1791403671.xml","form_type":"4"}},{"id":4636971,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2026-10-07T20:07:54.000Z","date":"2026-10-05","kind":"sale","planned":true,"acquired":false,"shares":19000,"price":86.74,"value":1648060.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025."}],"balance_after":27860,"source":{"system":"sec-edgar","filing":"0001960048-26-000013","document":"wk-form4_1791403671.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1960048/000196004826000013/wk-form4_1791403671.xml","form_type":"4"}},{"id":4636970,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2026-10-07T20:07:54.000Z","date":"2026-10-05","kind":"exercise","planned":true,"acquired":true,"shares":19000,"price":25.92,"value":492480.0,"ownership":{"direct":true},"balance_after":46860,"source":{"system":"sec-edgar","filing":"0001960048-26-000013","document":"wk-form4_1791403671.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1960048/000196004826000013/wk-form4_1791403671.xml","form_type":"4"}},{"id":4613714,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2026-09-09T21:52:14.000Z","date":"2026-09-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":1327,"price":60.36,"value":80097.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":27860,"source":{"system":"sec-edgar","filing":"0001960048-26-000011","document":"wk-form4_1788990731.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1960048/000196004826000011/wk-form4_1788990731.xml","form_type":"4"}},{"id":1429,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2026-09-02T23:54:51.000Z","date":"2026-09-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":326,"price":61.58,"value":20075.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":29187,"source":{"system":"sec-edgar","filing":"0001960048-26-000009","document":"wk-form4_1788393289.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1960048/000196004826000009/wk-form4_1788393289.xml","form_type":"4"}},{"id":1428,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2026-09-02T23:54:51.000Z","date":"2026-08-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":243,"price":60.74,"value":14759.82,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 781 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026."}],"balance_after":29513,"source":{"system":"sec-edgar","filing":"0001960048-26-000009","document":"wk-form4_1788393289.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1960048/000196004826000009/wk-form4_1788393289.xml","form_type":"4"}},{"id":812519,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Stock Option (right to buy)","published_at":"2026-04-08T20:32:44.000Z","date":"2026-04-07","kind":"exercise","planned":true,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the shares subject to the option vested on July 1, 2023, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date."}],"balance_after":93068,"derivative":{"exercise_price":25.92,"expiration_date":"2032-08-08","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001960048-26-000007","document":"wk-form4_1775680362.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000196004826000007/wk-form4_1775680362.xml","form_type":"4"}},{"id":812518,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2026-04-08T20:32:44.000Z","date":"2026-04-07","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":60,"value":180000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025."}],"balance_after":28975,"source":{"system":"sec-edgar","filing":"0001960048-26-000007","document":"wk-form4_1775680362.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000196004826000007/wk-form4_1775680362.xml","form_type":"4"}},{"id":812517,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2026-04-08T20:32:44.000Z","date":"2026-04-07","kind":"exercise","planned":true,"acquired":true,"shares":3000,"price":25.92,"value":77760.0,"ownership":{"direct":true},"balance_after":31975,"source":{"system":"sec-edgar","filing":"0001960048-26-000007","document":"wk-form4_1775680362.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000196004826000007/wk-form4_1775680362.xml","form_type":"4"}},{"id":834985,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2026-03-18T23:03:31.000Z","date":"2026-03-17","kind":"sale","planned":true,"acquired":false,"shares":405,"price":56.263,"value":22786.515,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025. No other shares of common stock subject to the restrictions on transfer set\nforth in a Lock-Up Agreement dated January 29, 2026 were sold by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $56.00 to $56.42. The reporting person will provide upon request to the SEC, the issuer or security holder\nof the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":28975,"source":{"system":"sec-edgar","filing":"0001960048-26-000005","document":"wk-form4_1773875008.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000196004826000005/wk-form4_1773875008.xml","form_type":"4"}},{"id":834984,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2026-03-18T23:03:31.000Z","date":"2026-03-17","kind":"sale","planned":true,"acquired":false,"shares":1487,"price":55.387,"value":82360.469,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025. No other shares of common stock subject to the restrictions on transfer set\nforth in a Lock-Up Agreement dated January 29, 2026 were sold by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $54.98 to $55.935. The reporting person will provide upon request to the SEC, the issuer or security holder\nof the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":29380,"source":{"system":"sec-edgar","filing":"0001960048-26-000005","document":"wk-form4_1773875008.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000196004826000005/wk-form4_1773875008.xml","form_type":"4"}},{"id":848659,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-11T21:23:56.000Z","date":"2026-03-11","kind":"exercise","planned":true,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the shares subject to the option vested on July 1, 2023, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date."}],"balance_after":96068,"derivative":{"exercise_price":25.92,"expiration_date":"2032-08-08","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001960048-26-000004","document":"wk-form4_1773264233.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000196004826000004/wk-form4_1773264233.xml","form_type":"4"}},{"id":848658,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2026-03-11T21:23:56.000Z","date":"2026-03-11","kind":"sale","planned":true,"acquired":false,"shares":2500,"price":58.5927,"value":146481.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025."}],"balance_after":30867,"source":{"system":"sec-edgar","filing":"0001960048-26-000004","document":"wk-form4_1773264233.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000196004826000004/wk-form4_1773264233.xml","form_type":"4"}},{"id":848657,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2026-03-11T21:23:56.000Z","date":"2026-03-11","kind":"exercise","planned":true,"acquired":true,"shares":2500,"price":25.92,"value":64800.0,"ownership":{"direct":true},"balance_after":33367,"source":{"system":"sec-edgar","filing":"0001960048-26-000004","document":"wk-form4_1773264233.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000196004826000004/wk-form4_1773264233.xml","form_type":"4"}},{"id":848656,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2026-03-11T21:23:56.000Z","date":"2026-03-09","kind":"tax_withholding","planned":true,"acquired":false,"shares":495,"price":59.32,"value":29363.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. No other shares of common stock subject to the restrictions on transfer set forth in a Lock-Up Agreement dated January 29, 2026 were sold by the Reporting Person."}],"balance_after":30867,"source":{"system":"sec-edgar","filing":"0001960048-26-000004","document":"wk-form4_1773264233.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000196004826000004/wk-form4_1773264233.xml","form_type":"4"}},{"id":874083,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-03T01:08:35.000Z","date":"2026-02-26","kind":"exercise","planned":false,"acquired":false,"shares":7716,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4 of the shares subject to the option vested on July 1, 2023, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date."}],"balance_after":98568,"derivative":{"exercise_price":25.92,"expiration_date":"2032-08-08","underlying":"Common Stock","underlying_shares":7716},"source":{"system":"sec-edgar","filing":"0001960048-26-000002","document":"wk-form4_1772500112.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000196004826000002/wk-form4_1772500112.xml","form_type":"4"}},{"id":874082,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-03T01:08:35.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":17855,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48 of shares subject to the option vest on March 26, 2026, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date."}],"balance_after":17855,"derivative":{"exercise_price":60,"expiration_date":"2036-02-26","underlying":"Common Stock","underlying_shares":17855},"source":{"system":"sec-edgar","filing":"0001960048-26-000002","document":"wk-form4_1772500112.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000196004826000002/wk-form4_1772500112.xml","form_type":"4"}},{"id":874081,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2026-03-03T01:08:35.000Z","date":"2026-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":326,"price":61.98,"value":20205.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":31362,"source":{"system":"sec-edgar","filing":"0001960048-26-000002","document":"wk-form4_1772500112.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000196004826000002/wk-form4_1772500112.xml","form_type":"4"}},{"id":874080,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2026-03-03T01:08:35.000Z","date":"2026-02-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":243,"price":61.98,"value":15061.14,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":31688,"source":{"system":"sec-edgar","filing":"0001960048-26-000002","document":"wk-form4_1772500112.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000196004826000002/wk-form4_1772500112.xml","form_type":"4"}},{"id":874079,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2026-03-03T01:08:35.000Z","date":"2026-02-26","kind":"exercise","planned":false,"acquired":true,"shares":7716,"price":25.92,"value":199998.72,"ownership":{"direct":true},"balance_after":31931,"source":{"system":"sec-edgar","filing":"0001960048-26-000002","document":"wk-form4_1772500112.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000196004826000002/wk-form4_1772500112.xml","form_type":"4"}},{"id":874078,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2026-03-03T01:08:35.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":10681,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs vest as to 1/4 of the shares subject to the award on September 7, 2026 and 1/8 of the shares every six months thereafter, subject to Reporting Person's continuous service with the Issuer through each such date."}],"balance_after":24215,"source":{"system":"sec-edgar","filing":"0001960048-26-000002","document":"wk-form4_1772500112.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000196004826000002/wk-form4_1772500112.xml","form_type":"4"}},{"id":958173,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE"}}],"security":"Common Stock","published_at":"2025-12-29T22:49:11.000Z","date":"2025-12-23","kind":"gift","planned":false,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects the bona-fide gift of the Issuer's common stock to a Charitable Donor Advised Fund."}],"balance_after":13534,"source":{"system":"sec-edgar","filing":"0001960048-25-000010","document":"wk-form4_1767048548.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000196004825000010/wk-form4_1767048548.xml","form_type":"4"}},{"id":958172,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE"}}],"security":"Common Stock","published_at":"2025-12-29T22:49:11.000Z","date":"2025-12-23","kind":"sale","planned":false,"acquired":false,"shares":6716,"price":47.935,"value":321931.46,"ownership":{"direct":true},"balance_after":14534,"source":{"system":"sec-edgar","filing":"0001960048-25-000010","document":"wk-form4_1767048548.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000196004825000010/wk-form4_1767048548.xml","form_type":"4"}},{"id":958171,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE"}}],"security":"Common Stock","published_at":"2025-12-29T22:49:11.000Z","date":"2025-12-23","kind":"sale","planned":false,"acquired":false,"shares":4907,"price":47.899,"value":235040.393,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes one (1) share acquired on November 17, 2025 under the Issuer's Employee Stock Purchase Plan."}],"balance_after":21250,"source":{"system":"sec-edgar","filing":"0001960048-25-000010","document":"wk-form4_1767048548.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000196004825000010/wk-form4_1767048548.xml","form_type":"4"}},{"id":1043997,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE"}}],"security":"Common Stock","published_at":"2025-09-10T20:28:24.000Z","date":"2025-09-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":482,"price":32.41,"value":15621.62,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":26156,"source":{"system":"sec-edgar","filing":"0001960048-25-000008","document":"wk-form4_1757536101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000196004825000008/wk-form4_1757536101.xml","form_type":"4"}},{"id":1047890,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE"}}],"security":"Common Stock","published_at":"2025-09-04T20:12:52.000Z","date":"2025-09-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":325,"price":31.56,"value":10257.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":26638,"source":{"system":"sec-edgar","filing":"0001960048-25-000007","document":"wk-form4_1757016769.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000196004825000007/wk-form4_1757016769.xml","form_type":"4"}},{"id":1047889,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE"}}],"security":"Common Stock","published_at":"2025-09-04T20:12:52.000Z","date":"2025-09-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":242,"price":31.56,"value":7637.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":26963,"source":{"system":"sec-edgar","filing":"0001960048-25-000007","document":"wk-form4_1757016769.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000196004825000007/wk-form4_1757016769.xml","form_type":"4"}},{"id":1052878,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE"}}],"security":"Stock Option (right to buy)","published_at":"2025-08-30T00:08:15.000Z","date":"2025-08-29","kind":"grant","planned":false,"acquired":true,"shares":9743,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48 of shares subject to the option vest on September 29, 2025, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date."}],"balance_after":9743,"derivative":{"exercise_price":30.79,"expiration_date":"2035-08-29","underlying":"Common Stock","underlying_shares":9743},"source":{"system":"sec-edgar","filing":"0001960048-25-000006","document":"wk-form4_1756512492.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000196004825000006/wk-form4_1756512492.xml","form_type":"4"}},{"id":1052877,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE"}}],"security":"Common Stock","published_at":"2025-08-30T00:08:15.000Z","date":"2025-09-07","kind":"grant","planned":false,"acquired":true,"shares":2810,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs vest as to 25% of the shares subject to the award on March 7, 2026 and 12.5% of the shares every six months thereafter, subject to Reporting Person's continuous service with the Issuer through each such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 289 shares acquired under the Issuer's Employee Stock Purchase Plan on May 16, 2025."}],"balance_after":27205,"source":{"system":"sec-edgar","filing":"0001960048-25-000006","document":"wk-form4_1756512492.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000196004825000006/wk-form4_1756512492.xml","form_type":"4"}},{"id":1235753,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-04T02:16:15.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":17961,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48 of shares subject to the option vest on March 27, 2025, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date."}],"balance_after":17961,"derivative":{"exercise_price":74.22,"expiration_date":"2035-02-26","underlying":"Common Stock","underlying_shares":17961},"source":{"system":"sec-edgar","filing":"0001649094-25-000041","document":"wk-form4_1741054569.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000041/wk-form4_1741054569.xml","form_type":"4"}},{"id":1235752,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE"}}],"security":"Common Stock","published_at":"2025-03-04T02:16:15.000Z","date":"2025-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":325,"price":72.1,"value":23432.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":24106,"source":{"system":"sec-edgar","filing":"0001649094-25-000041","document":"wk-form4_1741054569.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000041/wk-form4_1741054569.xml","form_type":"4"}},{"id":1235751,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE"}}],"security":"Common Stock","published_at":"2025-03-04T02:16:15.000Z","date":"2025-02-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":242,"price":73.02,"value":17670.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":24431,"source":{"system":"sec-edgar","filing":"0001649094-25-000041","document":"wk-form4_1741054569.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000041/wk-form4_1741054569.xml","form_type":"4"}},{"id":1235750,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE"}}],"security":"Common Stock","published_at":"2025-03-04T02:16:15.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":5379,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The\nRSUs vest as to 25% of the shares subject to the award on September 7, 2025 and 12.5% of the shares every six months thereafter, subject to Reporting Person's continuous service with the Issuer\nthrough each such date."}],"balance_after":24673,"source":{"system":"sec-edgar","filing":"0001649094-25-000041","document":"wk-form4_1741054569.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000041/wk-form4_1741054569.xml","form_type":"4"}},{"id":1326668,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE"}}],"security":"Stock Option (right to buy)","published_at":"2024-12-18T21:13:19.000Z","date":"2024-12-16","kind":"exercise","planned":false,"acquired":false,"shares":7716,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4 of the shares subject to the option vested on July 1, 2023, and 1/48 of the shares  vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date."}],"balance_after":106284,"derivative":{"exercise_price":25.92,"expiration_date":"2032-08-08","underlying":"Common Stock","underlying_shares":7716},"source":{"system":"sec-edgar","filing":"0001649094-24-000124","document":"wk-form4_1734556392.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000124/wk-form4_1734556392.xml","form_type":"4"}},{"id":1326667,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE"}}],"security":"Common Stock","published_at":"2024-12-18T21:13:19.000Z","date":"2024-12-16","kind":"exercise","planned":false,"acquired":true,"shares":7716,"price":25.92,"value":199998.72,"ownership":{"direct":true},"balance_after":19294,"source":{"system":"sec-edgar","filing":"0001649094-24-000124","document":"wk-form4_1734556392.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000124/wk-form4_1734556392.xml","form_type":"4"}},{"id":1371365,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE"}}],"security":"Performance Stock Option (right to buy)","published_at":"2024-11-09T01:51:03.000Z","date":"2024-11-07","kind":"grant","planned":false,"acquired":true,"shares":11900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"As part of a company-wide grant to all eligible employees of the Issuer, on November 7, 2024 (the \"Grant Date\"), the Reporting Person was granted a performance stock option to purchase 11,900\nshares of the Issuer's Common Stock at a per share exercise price of $102.70. The option is subject to (1) a service-based vesting condition (vesting as to one-third of the shares on each of the third, fourth\nand fifth anniversaries of the Grant Date) and (2) a performance-vesting condition (which generally requires that the trading price of the Issuer's Common Stock average, over a one-year period, is at least $154.05 (150% of the Grant Date closing price))."}],"balance_after":11900,"derivative":{"exercise_price":102.7,"expiration_date":"2034-11-06","underlying":"Common Stock","underlying_shares":11900},"source":{"system":"sec-edgar","filing":"0001649094-24-000109","document":"wk-form4_1731117057.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000109/wk-form4_1731117057.xml","form_type":"4"}},{"id":1413913,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE"}}],"security":"Stock Option (right to buy)","published_at":"2024-09-05T21:15:21.000Z","date":"2024-09-03","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the shares subject to the option vested on July 1, 2023, and 1/48 of the shares shall vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date."}],"balance_after":114000,"derivative":{"exercise_price":25.92,"expiration_date":"2032-08-08","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001649094-24-000063","document":"wk-form4_1725570915.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000063/wk-form4_1725570915.xml","form_type":"4"}},{"id":1413912,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE"}}],"security":"Common Stock","published_at":"2024-09-05T21:15:21.000Z","date":"2024-09-03","kind":"tax_withholding","planned":true,"acquired":false,"shares":1145,"price":110.15,"value":126121.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of restricted stock units. No other shares of common stock subject to the restrictions on transfer set forth in a Lock-Up Agreement dated September 4, 2024 were sold by the Reporting Person."}],"balance_after":11578,"source":{"system":"sec-edgar","filing":"0001649094-24-000063","document":"wk-form4_1725570915.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000063/wk-form4_1725570915.xml","form_type":"4"}},{"id":1413911,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE"}}],"security":"Common Stock","published_at":"2024-09-05T21:15:21.000Z","date":"2024-09-03","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":107.67,"value":538350.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 13, 2023."}],"balance_after":12723,"source":{"system":"sec-edgar","filing":"0001649094-24-000063","document":"wk-form4_1725570915.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000063/wk-form4_1725570915.xml","form_type":"4"}},{"id":1413910,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE"}}],"security":"Common Stock","published_at":"2024-09-05T21:15:21.000Z","date":"2024-09-03","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":25.92,"value":129600.0,"ownership":{"direct":true},"balance_after":17723,"source":{"system":"sec-edgar","filing":"0001649094-24-000063","document":"wk-form4_1725570915.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000063/wk-form4_1725570915.xml","form_type":"4"}},{"id":1452571,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE"}}],"security":"Stock Option (right to buy)","published_at":"2024-07-17T20:03:15.000Z","date":"2024-07-16","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the shares subject to the option vested on July 1, 2023, and 1/48 of the shares shall vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date."}],"balance_after":119000,"derivative":{"exercise_price":25.92,"expiration_date":"2032-08-08","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001649094-24-000036","document":"wk-form4_1721246588.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000036/wk-form4_1721246588.xml","form_type":"4"}},{"id":1452570,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE"}}],"security":"Common Stock","published_at":"2024-07-17T20:03:15.000Z","date":"2024-07-16","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":85,"value":425000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 13, 2023."}],"balance_after":12723,"source":{"system":"sec-edgar","filing":"0001649094-24-000036","document":"wk-form4_1721246588.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000036/wk-form4_1721246588.xml","form_type":"4"}},{"id":1452569,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE"}}],"security":"Common Stock","published_at":"2024-07-17T20:03:15.000Z","date":"2024-07-16","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":25.92,"value":129600.0,"ownership":{"direct":true},"balance_after":17723,"source":{"system":"sec-edgar","filing":"0001649094-24-000036","document":"wk-form4_1721246588.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000036/wk-form4_1721246588.xml","form_type":"4"}},{"id":1457560,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE"}}],"security":"Stock Option (right to buy)","published_at":"2024-07-09T21:15:43.000Z","date":"2024-07-08","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the shares subject to the option vested on July 1, 2023, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date."}],"balance_after":124000,"derivative":{"exercise_price":25.92,"expiration_date":"2032-08-08","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001649094-24-000034","document":"wk-form4_1720559736.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000034/wk-form4_1720559736.xml","form_type":"4"}},{"id":1457559,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE"}}],"security":"Common Stock","published_at":"2024-07-09T21:15:43.000Z","date":"2024-07-08","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":80,"value":400000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 13, 2023."}],"balance_after":12723,"source":{"system":"sec-edgar","filing":"0001649094-24-000034","document":"wk-form4_1720559736.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000034/wk-form4_1720559736.xml","form_type":"4"}},{"id":1457558,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE"}}],"security":"Common Stock","published_at":"2024-07-09T21:15:43.000Z","date":"2024-07-08","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":25.92,"value":129600.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 567 shares acquired under the Issuer's Employee Stock Purchase Plan on May 17, 2024."}],"balance_after":17723,"source":{"system":"sec-edgar","filing":"0001649094-24-000034","document":"wk-form4_1720559736.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000034/wk-form4_1720559736.xml","form_type":"4"}},{"id":1603078,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-05T02:22:22.000Z","date":"2024-03-01","kind":"exercise","planned":true,"acquired":false,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"1/4 of the shares subject to the option shall vest on July 1, 2023, and 1/48 of the shares shall vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date."}],"balance_after":129000,"derivative":{"exercise_price":25.92,"expiration_date":"2032-08-08","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001415889-24-006475","document":"form4-03052024_020305.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924006475/form4-03052024_020305.xml","form_type":"4"}},{"id":1603077,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-05T02:22:22.000Z","date":"2024-02-29","kind":"grant","planned":true,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"1/48 of shares subject to the option vest on March 31, 2024, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date."}],"balance_after":25000,"derivative":{"exercise_price":73.82,"expiration_date":"2024-02-28","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-24-006475","document":"form4-03052024_020305.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924006475/form4-03052024_020305.xml","form_type":"4"}},{"id":1603076,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE"}}],"security":"Common Stock","published_at":"2024-03-05T02:22:22.000Z","date":"2024-03-02","kind":"tax_withholding","planned":true,"acquired":false,"shares":324,"price":71.55,"value":23182.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F7","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of restricted stock units."}],"balance_after":12156,"source":{"system":"sec-edgar","filing":"0001415889-24-006475","document":"form4-03052024_020305.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924006475/form4-03052024_020305.xml","form_type":"4"}},{"id":1603075,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE"}}],"security":"Common Stock","published_at":"2024-03-05T02:22:22.000Z","date":"2024-03-01","kind":"sale","planned":true,"acquired":false,"shares":4901,"price":74.9,"value":367084.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 13, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $74.47 to $75.02. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":12480,"source":{"system":"sec-edgar","filing":"0001415889-24-006475","document":"form4-03052024_020305.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924006475/form4-03052024_020305.xml","form_type":"4"}},{"id":1603074,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE"}}],"security":"Common Stock","published_at":"2024-03-05T02:22:22.000Z","date":"2024-03-01","kind":"sale","planned":true,"acquired":false,"shares":4455,"price":73.689,"value":328284.495,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 13, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $73.42 to $74.465. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":17381,"source":{"system":"sec-edgar","filing":"0001415889-24-006475","document":"form4-03052024_020305.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924006475/form4-03052024_020305.xml","form_type":"4"}},{"id":1603073,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE"}}],"security":"Common Stock","published_at":"2024-03-05T02:22:22.000Z","date":"2024-03-01","kind":"sale","planned":true,"acquired":false,"shares":2322,"price":73.084,"value":169701.048,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 13, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $72.39 to $73.365. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":21836,"source":{"system":"sec-edgar","filing":"0001415889-24-006475","document":"form4-03052024_020305.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924006475/form4-03052024_020305.xml","form_type":"4"}},{"id":1603072,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE"}}],"security":"Common Stock","published_at":"2024-03-05T02:22:22.000Z","date":"2024-03-01","kind":"exercise","planned":true,"acquired":true,"shares":11000,"price":25.92,"value":285120.0,"ownership":{"direct":true},"balance_after":24158,"source":{"system":"sec-edgar","filing":"0001415889-24-006475","document":"form4-03052024_020305.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924006475/form4-03052024_020305.xml","form_type":"4"}},{"id":1603071,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE"}}],"security":"Common Stock","published_at":"2024-03-05T02:22:22.000Z","date":"2024-02-29","kind":"grant","planned":true,"acquired":true,"shares":5400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs vest as to 25% of the shares subject to the award on August 31, 2024 and 12.5% of the shares every six months thereafter, subject to Reporting Person's continuous service with the Issuer through each such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 457 shares acquired under the Vaxcyte, Inc. Employee Stock Purchase Plan on November 17, 2023."}],"balance_after":13158,"source":{"system":"sec-edgar","filing":"0001415889-24-006475","document":"form4-03052024_020305.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924006475/form4-03052024_020305.xml","form_type":"4"}},{"id":1787134,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance"}}],"security":"Common Stock","published_at":"2023-09-06T21:34:00.000Z","date":"2023-09-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":627,"price":51,"value":31977.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 678 shares acquired under the Issuer's Employee Stock Purchase Plan on May 17, 2023."}],"balance_after":7301,"source":{"system":"sec-edgar","filing":"0001209191-23-048468","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919123048468/doc4.xml","form_type":"4"}},{"id":1973469,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-03T22:11:41.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":43500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48 of shares subject to the option vest on April 1, 2023, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date."}],"balance_after":43500,"derivative":{"exercise_price":41.67,"expiration_date":"2033-03-01","underlying":"Common Stock","underlying_shares":43500},"source":{"system":"sec-edgar","filing":"0001209191-23-015729","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919123015729/doc4.xml","form_type":"4"}},{"id":1973468,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance"}}],"security":"Common Stock","published_at":"2023-03-03T22:11:41.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":7250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs vest as to 25% of the shares subject to the award on September 2, 2023 and 12.5% of the shares every six months thereafter, subject to Reporting Person's continuous service with the Issuer through each such date."}],"balance_after":7250,"source":{"system":"sec-edgar","filing":"0001209191-23-015729","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919123015729/doc4.xml","form_type":"4"}}]}